Thomas Malley

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Malley:

Insider Reports Filed by Thomas Malley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director
KURA Kura Oncology, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2023 2 $0 4 Jul 3, 2023 Director
KURA Kura Oncology, Inc. Jun 16, 2023 1 $575K 4 Jun 21, 2023 Director
BGNE BeiGene, Ltd. Jun 15, 2023 2 $0 4 Jun 20, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
KURA Kura Oncology, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2022 2 $0 4 Jun 30, 2022 Director
BGNE BeiGene, Ltd. Jun 22, 2022 2 $0 4 Jun 24, 2022 Director
KURA Kura Oncology, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
KURA Kura Oncology, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director
BGNE BeiGene, Ltd. Jun 16, 2021 2 $0 4 Jun 21, 2021 Director